Alamar Biosciences, Inc. ALMR 深 滬
已收盤 07-02 16:00:00 美东时间
25.94
-0.190
-0.73%
華盛通- 最 高26.66
- 今 開26.14
- 成交量 25.23万股
- 最 低 25.455
- 昨 收 26.13
- 總市值 17.98亿
- 52周最高 28.68
- 市盈率 靜 --
- 換手率 0.36%
- 52周最低 18.845
- 委 比 80.14%
- 總股本 6931.12万
- 歷史最高 28.68
- 量 比 0.29
- 振 幅 4.61%
- 歷史最低 18.845
- 每 手 1
- 風險率 2.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股夜盘 | Viridian Therapeutics, Inc.涨7.65%，AbCellera Biologics, Inc.涨6.91%
Viridian Therapeutics, Inc.涨7.65%；AbCellera Biologics, Inc.涨6.91%；Alamar Biosciences, Inc.涨5.92%
06-29 10:00
美股夜盘 | Viridian Therapeutics, Inc.涨12.29%，温迪-阿比斯饭店涨8.59%
Viridian Therapeutics, Inc.涨12.29%；温迪-阿比斯饭店涨8.59%；Vera Therapeutics, Inc. Class A涨7.68%
06-29 09:00
Why Friedman Industries Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Shares of Friedman Industries Inc (NASDAQ:FRD) rose sharply in pre-market trading after the company posted a sharp increase in earnings per share in fourth-quarter results. Friedman reported fourth-quarter net earnings of $9.2 million, or $1.30 diluted EPS, on sales of $191.8 million, up from $5.3 m...
06-12 17:29
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Stifel Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $28
Stifel analyst Daniel Arias initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Buy rating and announces Price Target of $28.
05-12 18:46
Alamar Biosciences Q1 EPS $(1.74), Sales $26.035M
Alamar Biosciences (NASDAQ:ALMR) reported quarterly losses of $(1.74) per share. The company reported $26.035 million in sales this quarter.
05-08 20:10
美股收盘：纳指13连涨！追平1992年以来最长连涨纪录；大型科技股悉数走强，特斯拉涨超3%，苹果涨超2%
伊朗开放霍尔木兹海峡，纳指涨超1.5%录得13连涨！追平1992年以来最长连涨纪录；大型科技股悉数走强，特斯拉涨超3%，苹果涨超2%；稀土概念股CRML大涨超35%>>
04-18 09:07
Proteomics firm Alamar climbs 40% after upsized IPO
Alamar Biosciences (ALMR) climbed ~40% on Friday after the commercial-stage proteomics company priced its upsized initial public offering of roughly 11.3M shares to raise approximately $191M in gross ...
04-18 01:25
UPDATE 1-Kailera, Alamar launch US IPOs as biotech listings gather momentum
UPDATE 1-Kailera, Alamar launch US IPOs as biotech listings gather momentum Changes media packaging code to USA-IPO/BIOTECH, adds details on Kailera and Alamar IPOs throughout April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offering
04-13 19:58
